[HTML][HTML] Kinase-targeted cancer therapies: progress, challenges and future directions

KS Bhullar, NO Lagarón, EM McGowan, I Parmar… - Molecular cancer, 2018 - Springer
The human genome encodes 538 protein kinases that transfer a γ-phosphate group from
ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with …

[HTML][HTML] Remodeling tumor microenvironment with natural products to overcome drug resistance

W Zhang, S Li, C Li, T Li, Y Huang - Frontiers in Immunology, 2022 - frontiersin.org
With cancer incidence rates continuing to increase and occurrence of resistance in drug
treatment, there is a pressing demand to find safer and more effective anticancer strategy for …

[HTML][HTML] The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells

H Cai, Y Xu - Cell communication and signaling, 2013 - Springer
Abstract Background The Hippo-YAP signaling pathway is altered and implicated as
oncogenic in many human cancers. However, extracellular signals that regulate the …

[HTML][HTML] Unraveling the anticancer effect of curcumin and resveratrol

AR Pavan, GDB Silva, DH Jornada, DE Chiba… - Nutrients, 2016 - mdpi.com
Resveratrol and curcumin are natural products with important therapeutic properties useful
to treat several human diseases, including cancer. In the last years, the number of studies …

A ROS/STAT3/HIF‐1α signaling cascade mediates EGF‐induced TWIST1 expression and prostate cancer cell invasion

KH Cho, MJ Choi, KJ Jeong, JJ Kim, MH Hwang… - The …, 2014 - Wiley Online Library
BACKGROUND Epidermal growth factor (EGF) has been known to induce epithelial–
mesenchymal transition (EMT) and prostate cancer cell progression. However, a detailed …

The Hippo pathway as a drug target in gastric cancer

Y Qiao, T Li, S Zheng, H Wang - Cancer Letters, 2018 - Elsevier
The Hippo tumor suppressor pathway is critical for balancing cellular differentiation and
proliferation in response to cell-cell contact, mechanical signals and diffusible signals such …

Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease

Y Zhou, PJ Little, HT Ta, S Xu, D Kamato - Pharmacology & Therapeutics, 2019 - Elsevier
Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six
widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological …

Biomarkers for early detection of ovarian cancer

L Nguyen, SJ Cardenas-Goicoechea… - Women's …, 2013 - journals.sagepub.com
Ovarian cancer is the most lethal gynecological malignancy. However, effective screening
strategies have not been established and continue to be elusive. A good screening test must …

Lysophosphatidic acid receptor antagonism protects against diabetic nephropathy in a type 2 diabetic model

MZ Zhang, X Wang, H Yang, AB Fogo… - Journal of the …, 2017 - journals.lww.com
Lysophosphatidic acid (LPA) functions through activation of LPA receptors (LPARs). LPA–
LPAR signaling has been implicated in development of fibrosis. However, the role of LPA …

[HTML][HTML] Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis

YN Kim, SR Choe, KH Cho, DY Cho, J Kang… - … & Molecular Medicine, 2017 - nature.com
Hippo/YAP signaling is implicated in tumorigenesis and progression of various cancers. By
inhibiting a plethora signaling cascades, resveratrol has strong anti-tumorigenic and anti …